GHK-Cu vs SNAP-8 (Acetyl Octapeptide-3)
A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
GHK-Cu
GHK-Cu is a naturally occurring copper peptide found in human plasma, saliva, and urine. It plays a role in wound healing, skin regeneration, and anti-inflammatory signaling. Levels decline significantly with age, which has driven interest in topical and injectable supplementation.
Full profileSNAP-8 (Acetyl Octapeptide-3)
8-amino acid cosmetic peptide active (Acetyl Octapeptide-3) that competes with SNARE complex proteins to reduce neuromuscular signal transmission in facial expression muscles. An extended, more potent version of Argireline (Acetyl Hexapeptide-3). Clinical studies show 26–63% reduction in expression wrinkle depth with twice-daily application, positioning it as a topical botulinum toxin alternative.
Full profile| GHK-Cu | SNAP-8 (Acetyl Octapeptide-3) | |
|---|---|---|
| Category | Anti-Aging & Longevity | Anti-Aging & Longevity |
| Also known as | Copper Peptide GHK-Cu, Glycyl-L-histidyl-L-lysine copper, Copper Tripeptide-1 | Leuphasyl, Acetyl Octapeptide-3, SNAP-8 peptide, Argireline extension, Acetyl Glutamyl Heptapeptide-3 |
| Evidence | Research-stage | Research-stage |
| Dosing range | 1mg–3mg mg, daily to every other day (injectable); twice daily (topical) | 1%–10% %, twice daily topical application |
| Administration | Subcutaneous injection, Topical application (cream, serum — most common consumer use), Intradermal injection (skincare clinics) | Topical (serum/cream) |
| Key side effects | Injection site redness (transient), Mild skin irritation with topical (typically resolves with reduced frequency), Rarely reported: metallic taste (with injectable use at higher doses) | Very well-tolerated, Rare mild skin irritation or redness, No systemic absorption at cosmetic concentrations, No paralysis risk (partial SNARE competition only) |
| Cited sources | 4 references | 2 references |
Key differences
- Administration: GHK-Cu — Subcutaneous injection, Topical application (cream, serum — most common consumer use), Intradermal injection (skincare clinics); SNAP-8 (Acetyl Octapeptide-3) — Topical (serum/cream).
- Dosing units differ: GHK-Cu is dosed in mg, SNAP-8 (Acetyl Octapeptide-3) in % — they operate at different scales.
- Frequency: GHK-Cu is typically daily to every other day (injectable); twice daily (topical); SNAP-8 (Acetyl Octapeptide-3) is twice daily topical application.
- Research depth: this profile cites 4 sources for GHK-Cu vs 2 for SNAP-8 (Acetyl Octapeptide-3).
How each works
GHK-Cu
GHK-Cu has been studied for its ability to stimulate collagen, elastin, and glycosaminoglycan synthesis, promote wound healing, and exhibit antioxidant and anti-inflammatory effects. Gene-expression work by Pickart and colleagues found GHK altered expression (>50% up or down) in roughly 32% of assayed human genes — the basis of the widely-cited '~4,000 genes' figure. Its evidence is strongest for in-vitro and topical/cosmetic use; robust human trials of injectable/systemic GHK-Cu are lacking.
SNAP-8 (Acetyl Octapeptide-3)
SNAP-8 mimics the N-terminal domain of SNAP-25, competing for SNARE complex assembly required for acetylcholine vesicle fusion at the neuromuscular junction. This partial inhibition reduces muscle contraction intensity without complete paralysis. Clinical studies demonstrate statistically significant reductions in crow's feet and forehead line depth after 28 days of use at 5–10% concentration.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.